Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 13226
Country/Region: Uganda
Year: 2014
Main Partner: Medical Access Uganda Limited
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $51,247,443 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Medical Access Uganda Ltd (MAUL) is a local and indigenous not for profit organization operational in Uganda since 1998 and it specializes in provision of supply chain management services for pharmaceutical products and health commodities. In 2013 MAUL provided supply chain management services for the CDC supported 12 Implementing partners to treat 193,000 patients on ART in over 212 Private Not For Profit (PNFP) sites across 53 districts in Uganda. The overall goal of the Health Logistics Project under MAUL is to support the centralized procurement, warehousing and distribution of HIV/AIDS-related commodities including ARVs, Cotrimoxazole, Safe Medical Male Circumcision kits, laboratory equipment, reagents and accessories plus HIV test kits for CDC funded HIV programs in private sector; and to strengthen the capacity of institutions to manage health commodities. Ensuring the availability and managing health commodities is a critical requirement to implement the Global Health Strategy. MAUL will continue to participate in the national quantification exercise with Global Fund, MOH, PEPFAR, UN agencies and other bilateral partners. MAUL will work towards strengthening existing M&E systems by continued support to the national logistics system and linkage of logistics data to DHIS II. MAUL will continue to strengthen the national supply chain system through training and mentoring of health workers, supporting the implementation of national logistic management tools and developing forecasting tools. MAUL will work closely with MOH and other partners to secure better prices especially for laboratory reagents based on national pooling across to achieve economies of scale.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,423,101
Care: Pediatric Care and Support (PDCS) $1,052,304
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $3,034,776
Biomedical Prevention: Blood Safety (HMBL) $236,000
Testing: HIV Testing and Counseling (HVCT) $2,092,037
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,991,259
Treatment: ARV Drugs (HTXD) $29,320,936
Treatment: Adult Treatment (HTXS) $11,308,406
Treatment: Pediatric Treatment (PDTX) $788,624
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

This mechanism has no published performance targets or indicators.